Chemfab Alkalis Ltd
Chemicals & Petrochemicals | Small Cap
Chemfab Alkalis Ltd, operating within the Chemical & Petrochemicals industry, demonstrates a mixed financial performance. The company shows strength in solvency and profitability, particularly in return on capital employed and return on assets. However, liquidity, efficiency, and growth metrics indicate areas needing attention. The Interest Coverage Ratio is strong, suggesting a good ability to meet interest obligations. While the company maintains a solid equity base, its revenue and earnings growth are weak, and it needs to improve its operational efficiency and liquidity to ensure long-term stability and competitiveness. The weighted average calculation method impacts these scores, emphasizing recent performance more heavily.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio2.80
- Financial Ratio4.60
- Profitability Ratio4.80
- Efficiency Ratio4.67
- Coverage Ratio6.80
- Solvency Ratio10.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayNeutral
- 1 WeekNeutral
- 1 MonthNeutral
Chemfab Alkalis Ltd, operating within the Chemical & Petrochemicals industry, demonstrates a mixed financial performance. The company shows strength in solvency and profitability, particularly in return on capital employed and return on assets. However, liquidity, efficiency, and growth metrics indicate areas needing attention. The Interest Coverage Ratio is strong, suggesting a good ability to meet interest obligations. While the company maintains a solid equity base, its revenue and earnings growth are weak, and it needs to improve its operational efficiency and liquidity to ensure long-term stability and competitiveness. The weighted average calculation method impacts these scores, emphasizing recent performance more heavily.
Overall Valuation Score
P/E RATIO (TTM)
-90.13
Industry Median
22.59
Small Cap Median
21.70
P/E RATIO
-87.70
P/B RATIO
1.60
Industry Median
1.76
Small Cap Median
1.77
P/S RATIO
1.83
Industry Median
0.89
Small Cap Median
0.88
Others
PEG RATIO
4.39
EV/EBITDA RATIO
14.52
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹423.6 as on May 14, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company shows mixed growth performance. Asset growth is a bright spot, but significant declines in operating profit and EPS growth raise concerns. While asset expansion is positive, the lack of corresponding profit growth suggests potential inefficiencies. Focusing on strategies to improve profitability is essential. The weighted average calculation highlights the impact of recent negative trends.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 50.28 | 21.69 | -1.21 | 2.14 | -6.89 |
| Operating Profit Growth Rate | 137.5 | 94.74 | -50.45 | -20 | -38.64 |
| Earnings Per Share (EPS) Growth | -451.9 | 123.89 | -59.38 | -126.11 | -50.52 |
| Asset Growth Rate | 5.07 | 17.05 | 21.36 | 4.4 | 10.54 |
| Net Income Growth Rate | -462.5 | 124.14 | -60 | -126.92 | -57.14 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The financial metrics paint a mixed picture. While capital expenditures are well-managed, there are areas. Improvement in Adjusted EPS, Book Value Per Share, and Dividend Per Share could strengthen investor confidence. The weighted average calculation method considers the recent trends in these metrics.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 20.71 | 47.86 | 18.57 | 6.43 | -2.14 |
| Cash Earnings Per Share (Cash EPS) | 36.43 | 62.86 | 34.29 | 20.71 | 17.86 |
| Book Value Per Share | 212.86 | 257.86 | 276.43 | 271.43 | 267.86 |
| Dividend Per Share (DPS) | 1.22 | 1.37 | 1.29 | 1.26 | 1.24 |
| Capital Expenditures (CapEx) | 19 | 53 | 92 | 111 | 76 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The profitability ratios highlight strengths in return on capital employed and return on assets, but weakness in margins. Strong ROCE and ROA indicate efficient use of capital and assets to generate profits. However, low gross, operating, and net margins suggest challenges in cost management and pricing strategies. Addressing these margin issues is critical for enhancing overall profitability. The weighted average calculation emphasizes recent performance trends.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 12.87 | 26.59 | 10.09 | 2.4 | -0.32 |
| Return on Capital Employed (ROCE) | 13 | 28 | 11 | 3 | 2 |
| Return on Equity (ROE) | 9.73 | 18.01 | 6.72 | -1.84 | -0.8 |
| Return on Assets (ROA) | 16.19 | 26.94 | 11 | 8.43 | 4.68 |
| Operating Margin | 20.96 | 33.53 | 16.82 | 13.17 | 8.68 |
| Net Margin | 10.66 | 19.64 | 7.95 | -2.1 | -0.96 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The efficiency metrics present a mixed picture. There is effective management in inventory and receivable collections, but there are potential inefficiencies in asset turnover. Improving the turnover of fixed assets and overall capital could enhance operational performance. The weighted average calculation emphasizes the need for consistent efficiency improvements.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 1.4 | 1.72 | 1.32 | 1.05 | 0.8 |
| Inventory Turnover Ratio | 22.57 | 16.83 | 17.88 | 15.16 | 11.77 |
| Receivables Turnover Ratio | 15.11 | 15.4 | 15.21 | 15.9 | 13.82 |
| Days Sales in Inventory Ratio | 16.17 | 21.69 | 20.41 | 24.08 | 31.01 |
| Receivable Days | 24.16 | 23.7 | 24 | 22.96 | 26.41 |
| Capital Turnover Ratio | 0.91 | 0.91 | 0.81 | 0.75 | 0.68 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The coverage ratios indicate a strong capacity to handle interest expenses, but there is no dividend coverage. The robust interest coverage is a significant strength, ensuring the company can comfortably meet its debt obligations. The weighted average calculation highlights the recent strength in interest coverage.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 40 | 90 | 20.5 | 1 | 1 |
| Equity Dividend Coverage Ratio | 16.67 | 33.33 | 14.29 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company demonstrates strong solvency. This indicates a solid financial structure with a high degree of equity and a low reliance on debt. This provides a stable base for long-term operations and reduces the risk of financial distress, offering stability and investor confidence.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.01 | 0.01 | 0.04 | 0.15 | 0.18 |
| Debt to Equity Ratio | 0.01 | 0.01 | 0.04 | 0.18 | 0.22 |
| Equity Ratio | 0.99 | 0.99 | 0.96 | 0.85 | 0.82 |
| Debt To Asset Ratio | 0.01 | 0 | 0.04 | 0.13 | 0.15 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The liquidity position reflects challenges in meeting short-term obligations. While a higher score is desirable, the current level suggests potential difficulties in covering immediate liabilities. This situation could limit the company's operational flexibility and its ability to seize growth opportunities. Chemical & Petrochemical companies often require substantial working capital, making efficient liquidity management crucial.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 2.25 | 2.52 | 1.83 | 2 | 1.24 |
| Quick Ratio | 2.02 | 2.17 | 1.66 | 1.64 | 1.02 |
| Cash Ratio | 0.15 | 0.08 | 0.26 | 0.07 | 0.01 |
| Operating Cash Flow Ratio | 1.04 | 1.94 | 0.33 | 0.53 | 0.32 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Sree Rayalaseema Hi-Strength Hypo Ltd | 8.63 | 9.33 | Undervalued | 88.00 | 54.00 | 90.00 |
| 2 | DMCC Speciality Chemicals Ltd | 8.11 | 22.92 | Neutral | 63.00 | 10.96 | 27.00 |
| 3 | Indo Borax & Chemicals Ltd | 8.10 | 23.24 | Highly Overvalued | 44.00 | 15.50 | 50.00 |
| 4 | Tamil Nadu Petro Products Ltd | 8.06 | 8.36 | Neutral | 131.00 | 9.87 | 97.00 |
| 5 | Indo Amines Ltd | 7.55 | 13.13 | Undervalued | 123.00 | 10.99 | 79.00 |
| 6 | Ganesh Benzoplast Ltd | 7.41 | 10.50 | Undervalued | 94.00 | 8.52 | 73.00 |
| 7 | Lords Chloro Alkali Ltd | 7.28 | 13.35 | Neutral | 63.00 | 9.94 | 28.00 |
| 8 | Amines & Plasticizers Ltd | 6.49 | 29.61 | Highly Overvalued | 60.00 | 6.63 | 37.00 |
| 9 | Fairchem Organics Ltd | 5.97 | 143.27 | Overvalued | 22.00 | 4.40 | 6.00 |
| 10 | Gulshan Polyols Ltd | 5.57 | 52.90 | Neutral | 134.00 | 17.18 | 43.00 |
| 11 | Mangalam Organics Ltd | 5.51 | 38.43 | Neutral | 88.00 | 16.01 | 26.00 |
| 12 | Chemfab Alkalis Ltd | 5.29 | -87.70 | Neutral | 27.00 | 5.22 | -3.00 |
| 13 | Kanoria Chemicals & Industries Ltd | 5.27 | -4.82 | Neutral | 71.00 | 7.88 | 113.00 |
Chemfab Alkalis Ltd's management effectiveness reveals a mixed performance. While the company shows sales growth, it struggles with consistent profit growth, evidenced by a significant decline in TTM profit growth. ROCE and ROE indicate potential capital efficiency issues. Although promoter holding remains substantial, a slight decrease is noted. Overall, despite growing sales, declining profitability and returns raise questions about management's operational efficiency and strategic decisions.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Sales Growth (5Y) | 10% | Demonstrates revenue expansion. |
| CONS | Compounded Profit Growth (TTM) | -115% | Indicates a significant decline in recent profitability. |
| CONS | ROCE (Mar 2025) | 3% | Suggests inefficient use of capital. |
| CONS | ROE (Last Year) | -1% | Suggests poor returns to shareholders. |
Financial Performance & Growth
Chemfab Alkalis Ltd's financial performance indicates some challenges. While sales have generally increased, profitability has been inconsistent. Compounded Sales Growth shows a TTM of 2%, a 3-Year growth of 7%, and a 5-Year growth of 10%. However, Compounded Profit Growth is concerning, with a TTM decline of -115%. Quarterly sales have varied, with OPM % declining from 33.47% in Mar 2023 to 14.45% in Mar 2025. Net Profit also shows a declining trend, dropping to -₹9.19 in Mar 2025. The inconsistent contribution from other income further impacts overall profitability.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Sales (₹ Cr) | 272 | 331 | 327 | 334 |
| OPM (%) | 21% | 33% | 17% | 13% |
| Net Profit (₹ Cr) | 29 | 65 | 26 | -7 |
Capital Efficiency & Returns
Chemfab Alkalis Ltd demonstrates concerning capital efficiency and returns. The ROCE % has significantly declined from 28% in Mar 2023 to 3% in Mar 2025. Similarly, ROE % also shows a downward trend, with a last year value of -1%. This indicates the company's struggles to generate returns from its capital and equity. The company's ROCE and ROE are below industry benchmarks.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| ROCE (%) | 13% | 28% | 10% | 3% |
Financial Health & Prudence
Chemfab Alkalis Ltd's financial health presents a mixed outlook. While the company initially decreased its borrowings from ₹ 43 Cr in Mar 2020 to ₹ 2 Cr in Mar 2023, there has been a recent increase to ₹ 84 Cr in Mar 2025. The interest coverage ratio, calculated as Operating Profit / Interest, has also decreased. The dividend payout has been inconsistent. The recent increase in borrowings warrants monitoring.
| Metric | Mar 2020 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Borrowings (₹ Cr) | 43 | 2 | 20 | 84 |
| Interest (₹ Cr) | 4 | 1 | 2 | 5 |
Shareholding & Ownership Structure
The shareholding pattern of Chemfab Alkalis Ltd indicates continued promoter confidence, though with a slight reduction over time. Promoter holding has decreased from 74.41% in Mar 2020 to 72.18% in Mar 2025. Institutional holding by FIIs is minimal, decreasing from 0.39% in Mar 2023 to 0.03% in Mar 2025, while DII holding remains very low at 0.27% in Mar 2025. The public holding has slightly increased.
| Metric | Mar 2020 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Promoters (%) | 74.41 | 73.11 | 72.88 | 72.18 |
| FIIs (%) | 0.00 | 0.39 | 0.35 | 0.03 |
The risk assessment for Chemfab Alkalis Ltd is rated 'Orange' due to a significant decline in profit growth, decreasing ROCE and ROE, and increasing debt level. These factors suggest a moderate level of risk, requiring close monitoring.
Accounting quality red flags
Tax % is 2,210% in Mar 2025
Segment performance volatility
Quarterly Sales and Profit show high fluctuations
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe